- Research
- Education
- Community Outreach
- News and Events
- About Us
- Donate Now
Learn more about what is involved by downloading our Study Participant Frequently Asked Questions (FAQ) or by contacting the research coordinator.
Download FAQ (PDF 53 KB)
Coronary Artery Stents
To evaluate the safety and effectiveness of the PROMUS Element™ Everolimus-Eluting Coronary Stent System (Boston Scientific Corporation [BSC], Natick, Massachusetts, United States) for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. More »
Research Coordinator: Holly MacDonald, RN, CCRC
To evaluate the safety and effectiveness of the drug-eluting Medtronic ENDEAVOR® Resolute Zotarolimus-Eluting Coronary Stent for the treatment of coronary artery blockages. More »
Research Coordinator: Gretchen Peichel, RN, CCRC and Jo Anne Goldman RT, RCIS, CCRC
